Gedeon Richter: Cariprazine has a real chance of becoming the best-selling atypical antipsychotic drug

Contributed by: PR Newswire

Tags

Gedeon-Richter

More Like This

Gedeon Richter: A new hope for treatment-resistant schizophrenia?

Gedeon Richter: Cariprazine shows effectiveness in the treatment for dual disorder

Gedeon Richter: an effective treatment for female schizophrenia patients

Gedeon Richter presents analysis on cannabis usage among patients with schizophrenia: a new medical solution to a severe issue might be available

PR Newswire associated0

Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences

PR Newswire associated0

Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences

Mundipharma and Cidara Therapeutics receive positive CHMP opinion for rezafungin for the treatment of Invasive Candidiasis in adults1

Mundipharma acquires all assets and rights related to REZZAYO® (rezafungin), reinforcing continued commitment to management of infectious diseases and specialty care therapeutic area